Open Orphan logo

ORPH - Open Orphan Share Price

15.25p 0.6  3.7%

Last Trade - 18/09/20

Small Cap
Market Cap £97.8m
Enterprise Value £100.1m
Revenue £3.51m
Position in Universe 952nd / 1806
Unlock ORPH Revenue
Relative Strength (%)
1m +11.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -10.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
4.88 11.5 17.9 17.4 13.9 3.84 30.1 35.0 -4.7%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Open Orphan PLC revenues decreased 72% to EUR3.8M. Net loss increased 37% to EUR6.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest costs increase from EUR6K to EUR344K (expense), Other operating income decrease of 47% to EUR195K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ORPH
Graphical History


ORPH Revenue Unlock ORPH Revenue

Net Income

ORPH Net Income Unlock ORPH Revenue

Normalised EPS

ORPH Normalised EPS Unlock ORPH Revenue

PE Ratio Range

ORPH PE Ratio Range Unlock ORPH Revenue

Dividend Yield Range

ORPH Dividend Yield Range Unlock ORPH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ORPH EPS Forecasts Unlock ORPH Revenue
Profile Summary

Open Orphan plc, formerly Venn Life Sciences Holdings plc, is engaged in the pharma services business. The Company is also engaged in building an orphan drug consulting services platform that helps pharma companies commercialize their products in Europe. The Company consists of four elements: a European clinical research organization and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians, and a Health Data Platform. The Company provides fragmented orphan drug services. The Company acquires and consolidates series of orphan drug services companies. It also provides digital data platforms to support companies in research & development and commercialization.

Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated February 2, 2011
Public Since December 14, 2012
No. of Shareholders: n/a
No. of Employees: 132
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 665,609,830
Free Float (0.0%)
Eligible for
ORPH Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ORPH
Upcoming Events for ORPH
Frequently Asked Questions for Open Orphan
What is the Open Orphan share price?

As of 18/09/20, shares in Open Orphan are trading at 15.25p, giving the company a market capitalisation of £97.8m. This share price information is delayed by 15 minutes.

How has the Open Orphan share price performed this year?

Shares in Open Orphan are currently trading at 15.25p and the price has moved by 0.131k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Open Orphan price has moved by 0.176k% over the past year.

What are the analyst and broker recommendations for Open Orphan?

Of the analysts with advisory recommendations for Open Orphan, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Open Orphan is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Open Orphan next release its financial results?

Open Orphan is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Open Orphan dividend yield?

Open Orphan does not currently pay a dividend.

Does Open Orphan pay a dividend?

Open Orphan does not currently pay a dividend.

When does Open Orphan next pay dividends?

Open Orphan does not currently pay a dividend.

How do I buy Open Orphan shares?

To buy shares in Open Orphan you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Open Orphan?

Shares in Open Orphan are currently trading at 15.25p, giving the company a market capitalisation of £97.8m.

Where are Open Orphan shares listed? Where are Open Orphan shares listed?

Here are the trading details for Open Orphan:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: ORPH
What kind of share is Open Orphan?

Based on an overall assessment of its quality, value and momentum, Open Orphan is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Open Orphan share price forecast 2020?

Shares in Open Orphan are currently priced at 15.25p. At that level they are trading at 49.16% discount to the analyst consensus target price of 30.00.

Analysts covering Open Orphan currently have a consensus Earnings Per Share (EPS) forecast of -0.008 for the next financial year.

How can I tell whether the Open Orphan share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Open Orphan. Over the past six months, the relative strength of its shares against the market has been 0.115k%. At the current price of 15.25p, shares in Open Orphan are trading at 54.74% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Open Orphan PE Ratio?

We were not able to find PE ratio data for Open Orphan.

Who are the key directors of Open Orphan?

Open Orphan's management team is headed by:

Paul Kennedy - NED
Anthony Richardson - CEO
Michael Ryan - NED
Gracielle Beijerbacht-Schutjens - EDR
Cornelis Groen - EDR
Allan Wood - CHM
Mary Sheahan - NED
David Kelly - NID
Leo Toole - CFO
Who are the major shareholders of Open Orphan?

Here are the top five shareholders of Open Orphan based on the size of their shareholding:

INVESCO Asset Management Limited Investment Advisor/Hedge Fund
Percentage owned: 7.89% (52.5m shares)
Friel (Cathal) Individual Investor
Percentage owned: 6.91% (46.0m shares)
IP Group PLC Venture Capital
Percentage owned: 6.05% (32.3m shares)
Invesco UK Equity High Income Mutual Fund
Percentage owned: 4.94% (32.9m shares)
Omnis Income & Growth Fund Mutual Fund
Percentage owned: 3.42% (18.8m shares)
Similar to ORPH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.